Related references
Note: Only part of the references are listed.Pregnancy and Lactation Associated Osteoporosis
Sarah A. Hardcastle
CALCIFIED TISSUE INTERNATIONAL (2022)
Premenopausal osteoporosis
M. Conradie et al.
CLIMACTERIC (2022)
Teriparatide Did Not Increase Adult Osteosarcoma Incidence in a 15-Year US Postmarketing Surveillance Study
Alicia Gilsenan et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2021)
Sclerostin: from bench to bedside
Sakae Tanaka et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2021)
Early Effects of Abaloparatide on Bone Formation and Resorption Indices in Postmenopausal Women With Osteoporosis
David W. Dempster et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2021)
Fragility fracture identifies patients at imminent risk for subsequent fracture: real-world retrospective database study in Ontario, Canada
Jonathan D. Adachi et al.
BMC MUSCULOSKELETAL DISORDERS (2021)
Anabolic Agents for Postmenopausal Osteoporosis: How Do You Choose?
Felicia Cosman et al.
CURRENT OSTEOPOROSIS REPORTS (2021)
Role of bone-forming agents in the management of osteoporosis
Michael R. McClung
AGING CLINICAL AND EXPERIMENTAL RESEARCH (2021)
Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2020)
A Randomized, Placebo-Controlled Study of Romosozumab for the Treatment of Hip Fractures
Emil H. Schemitsch et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2020)
Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Guideline Update
Dolores Shoback et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS—2020 UPDATE
Pauline M. Camacho et al.
Endocrine Practice (2020)
Romosozumab in Skeletally Mature Adults with a Fresh Unilateral Tibial Diaphyseal Fracture A Randomized Phase-2 Study
Mohit Bhandari et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2020)
Explanations for the difference in rates of cardiovascular events in a trial of alendronate and romosozumab
S. R. Cummings et al.
OSTEOPOROSIS INTERNATIONAL (2020)
Abaloparatide: an anabolic treatment to reduce fracture risk in postmenopausal women with osteoporosis
Paul D. Miller et al.
CURRENT MEDICAL RESEARCH AND OPINION (2020)
Nonclinical cardiovascular safety evaluation of romosozumab, an inhibitor of sclerostin for the treatment of osteoporosis in postmenopausal women at high risk of fracture
James R. Turk et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2020)
Effect of Teriparatide on Bone Remodeling and Density in Premenopausal Idiopathic Osteoporosis: A Phase II Trial
Adi Cohen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
A case of pregnancy and lactation associated osteoporosis in the third pregnancy; robust response to teriparatide despite delayed administration
Ethem Turgay Cerit et al.
BONE REPORTS (2020)
Osteoporotic Fractures of the Spine, Hip, and Other Locations after Adjuvant Endocrine Therapy with Aromatase Inhibitors in Breast Cancer Patients: a Meta-analysis
Young-Kyun Lee et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2020)
Effects of teriparatide on hip and upper limb fractures in patients with osteoporosis: A systematic review and meta-analysis
Adolfo Diez-Perez et al.
BONE (2019)
Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline
Richard Eastell et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Bone-Forming and Antiresorptive Effects of Romosozumab in Postmenopausal Women With Osteoporosis: Bone Histomorphometry and Microcomputed Tomography Analysis After 2 and 12 Months of Treatment
Pascale Chavassieux et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2019)
One Year of Romosozumab Followed by Two Years of Denosumab Maintains Fracture Risk Reductions: Results of the FRAME Extension Study
E. Michael Lewiecki et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2019)
Risk of subsequent fracture after prior fracture among older women
A. Balasubramanian et al.
OSTEOPOROSIS INTERNATIONAL (2019)
Update on the safety and efficacy of teriparatide in the treatment of osteoporosis
Salvatore Minisola et al.
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2019)
Romosozumab treatment in postmenopausal women with osteoporosis: a meta-analysis of randomized controlled trials
Y. Liu et al.
CLIMACTERIC (2018)
Effects of 24 Months of Treatment With Romosozumab Followed by 12 Months of Denosumab or Placebo in Postmenopausal Women With Low Bone Mineral Density: A Randomized, Double-Blind, Phase 2, Parallel Group Study
Michael R. McClung et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2018)
ACTIVExtend: 24 Months of Alendronate After 18 Months of Abaloparatide or Placebo for Postmenopausal Osteoporosis
Henry G. Bone et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial
David L. Kendler et al.
LANCET (2018)
Characteristics of recurrent fractures
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2018)
Effects of Romosozumab Compared With Teriparatide on Bone Density and Mass at the Spine and Hip in Postmenopausal Women With Low Bone Mass
Harry K. Genant et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2017)
Greater Gains in Spine and Hip Strength for Romosozumab Compared With Teriparatide in Postmenopausal Women With Low Bone Mass
Tony M. Keaveny et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2017)
Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial
Bente L. Langdahl et al.
LANCET (2017)
Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis
Kenneth G. Saag et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Comparing the incidence of bone tumors in rats chronically exposed to the selective PTH type 1 receptor agonist abaloparatide or PTH(1-34)
Jacquelin Jolette et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2017)
Vertebral Fractures: Clinical Importance and Management
D. L. Kendler et al.
AMERICAN JOURNAL OF MEDICINE (2016)
Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis A Randomized Clinical Trial
Paul D. Miller et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Romosozumab Treatment in Postmenopausal Women with Osteoporosis
F. Cosman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Second fractures among older adults in the year following hip, shoulder, or wrist fracture
J. P. W. Bynum et al.
OSTEOPOROSIS INTERNATIONAL (2016)
5-year follow-up of a randomized controlled trial of immediate versus delayed zoledronic acid for the prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen: N03CC (Alliance) trial
Nina D. Wagner-Johnston et al.
CANCER (2015)
Management of bone disease in women after breast cancer
F. Milat et al.
CLIMACTERIC (2015)
Antiresorptives and anabolic therapy in sequence or combination for postmenopausal osteoporosis
S. Palacios et al.
CLIMACTERIC (2015)
Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial
Benjamin Z. Leder et al.
LANCET (2015)
Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial
Michael Gnant et al.
LANCET (2015)
Two Years of Denosumab and Teriparatide Administration in Postmenopausal Women With Osteoporosis (The DATA Extension Study): A Randomized Controlled Trial
Benjamin Z. Leder et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Teriparatide Increases Strength of the Peripheral Skeleton in Premenopausal Women With Idiopathic Osteoporosis: A Pilot HR-pQCT Study
Kyle K. Nishiyama et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Romosozumab in Postmenopausal Women with Low Bone Mineral Density
Michael R. McClung et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Effects of Intravenous Zoledronic Acid Plus Subcutaneous Teriparatide [rhPTH(1-34)] in Postmenopausal Osteoporosis
Felicia Cosman et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Treatment with teriparatide in a patient with pregnancy-associated osteoporosis
Lars Hellmeyer et al.
GYNECOLOGICAL ENDOCRINOLOGY (2010)
Teriparatide for Acceleration of Fracture Repair in Humans: A Prospective, Randomized, Double-Blind Study of 102 Postmenopausal Women With Distal Radial Fractures
Per Aspenberg et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Clinical subsequent fractures cluster in time after first fractures
T. A. C. M. van Geel et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Effect of raloxifene after recombinant teriparatide [hPTH(1-34)] treatment in postmenopausal women with osteoporosis
S. Adami et al.
OSTEOPOROSIS INTERNATIONAL (2008)
Teriparatide or alendronate in glucocorticoid-induced osteoporosis
Kenneth G. Saag et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Combination teriparatide and raloxifene therapy for postmenopausal osteoporosis: Results from a 6-month double-blind placebo-controlled trial
C Deal et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
Differential effects of teriparatide and alendronate on bone remodeling in postmenopausal women assessed by histomorphometric parameters
M Arlot et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
Ten years' experience with alendronate for osteoporosis in postmenopausal women
HG Bone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Bone neoplasms in F344 rats given teriparatide [rhPTH(1-34)] are dependent on duration of treatment and dose
JL Vahle et al.
TOXICOLOGIC PATHOLOGY (2004)
Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.
RM Neer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Risk of new vertebral fracture in the year following a fracture
R Lindsay et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Share Paper
